Taken together, these results support the deregulation of arginine synthesis after HSP90 inhibition as a key mechanism with the potential to block cell proliferation in lung adenocarcinoma with mutated EGFR or EML4-ALK translocation. The gene discussed is EGFR; the disease is lung adenocarcinoma.